OK Biotech reports September revenue of NT$217.0M
OK Biotech Co. Ltd. reported September revenue of NT$217,013,000 versus NT$135,645,000 in the prior period, and Jan–Sep revenue of NT$1,389,854,000 versus NT$1,219,744,000.
OK Biotech Co. Ltd. reported revenue of NT$217,013,000 for 2026, compared with NT$135,645,000 in 2025. For Jan-Sep, revenue was NT$1,389,854,000 versus NT$1,219,744,000 a year earlier.
Source: Taiwan Stock Exchange.